RLT
0.75
134.4%
88E
0.001
-50%
H2G
0.006
100%
NRZ
0.001
-50%
WOA
0.029
61.1%
TOU
0.008
-46.7%
PR2
0.079
33.9%
ALM
0.003
-40%
CTN
0.004
33.3%
CKA
0.036
-40%
BEZ
0.037
32.1%
ANR
0.007
-36.4%
STN
0.255
27.5%
DTM
0.004
-33.3%
SHO
0.028
27.3%
ECT
0.002
-33.3%
MLX
0.665
26.7%
NTM
0.002
-33.3%
AGR
0.049
25.6%
PUA
0.007
-30%
SMX
0.049
25.6%
OVT
0.005
-28.6%
AZY
0.47
25.3%
ID8
0.008
-27.3%
ADG
0.005
25%
CYB
0.073
-27%
LEG
0.01
25%
SLH
1.54
-22.2%
NMG
0.015
25%
OEC
0.09
-21.7%
VMC
0.12
25%
SNX
0.018
-21.7%
WSR
0.01
25%
RML
0.011
-21.4%
RWL
0.28
24.4%
RMS
2.2
-21.1%
EGR
0.155
24%
BSX
0.057
-20.8%
PSC
0.105
23.5%
CUE
0.1
-20%

AML3D (ASX:AL3): Achieves most successful year on record

AML3D (ASX:AL3) has released its Annual Report, highlighting 1005% revenue growth over a period in which the company focussed on the continued delivery of its “US Scale-up” strategy and achieved its most successful year on record.

🔹 The “US Scaleup” strategy is focussed on supplying the AML3D’s proprietary ARCEMY® metal 3D printing systems and contract manufacturing services to industrial manufacturers in and supporting the US Defence, Marine and Aerospace industries.
🔹 The “US Scale-up” strategy underpinned a more than ten-fold increase in AML3D’s revenues during the financial year, when compared to the prior year.
🔹 Looking ahead AML3D is confident the demand from the US Defence market will remain strong and convert into continued US ARCEMY® sales and contract manufacturing orders during FY25 and says its contract manufacturing facility continues to deliver on the its current order book and retains the capacity to support additional contract manufacturing orders

2024 Annual report ⚡ https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02843864-6A1222196&v=fc9bdb61fe50ea61f8225e24ce041a0e155a9400